Treatment with metoclopramide can cause tardive dyskinesia (TD), a potentially irreversible and disfiguring disorder
San Diego, CA (PRWEB) January 15, 2013
AttorneyOne.com, a recognized authority on law, updated their website recently and they are now actively providing expert opinions in view of the recent news on Reglan lawsuits.
As The New York Times published on January 11th, 2013, Alabama Supreme Court ruled that a patient could sue the brand-name company for failing to warn about Reglan’s risks if the patient was injured by the generic form made by other manufacturers (case no. 1:2010cv00602). Reglan (metoclopramide) is a drug used to help with the digestive process and reduce the symptoms of acid reflux and heartburn. It has been in the market since 1996. In the lawsuit plaintiff claims he took generic version of Reglan to treat his acid reflux and he developed tardive dyskinesia. Plaintiff sued the brand-name company and the generic companies that made the drugs he took.
In November 2010, the FDA issued a warning on Reglan (metoclopramide) stating that “Treatment with metoclopramide can cause tardive dyskinesia (TD), a potentially irreversible and disfiguring disorder characterized by involuntary movements of the face, tongue, or extremities. The risk of developing tardive dyskinesia increases with the duration of treatment and the total cumulative dose.”
According to court documents, on December 10th, 2012, a Michigan man filed a product liabilities claim at Philadelphia Court of Common Pleas (case no. 121201046) alleging he suffered tardive dyskinesia from his use of Reglan.
Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in case of alleged Reglan severe complications. Sean Burke, director of Media Relations for AttorneyOne.com, adds that the relevant information illustrates that people continue to file Reglan lawsuits. "For that reason", he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”
In 2009, the US FDA issued a black box warning that treatment with metoclopramide (Reglan) can cause tardive dyskinesia, a serious movement disorder that is often irreversible.
AttorneyOne.com has further information on Reglan lawsuits including how to get in contact with legal counsel.
Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2013/1/prweb10318171.htm